MINT Conditioning to Improve Gait
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorNorthwestern University
About this trial
This study will test the ability of myoelectric interface for neurorehabilitation (MINT) training to improve walking function.
Eligibility criteria
Qualifiers
Age at enrollment is 18 to 85
Leg impairment from unilateral stroke at least 6 months prior to screening
Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m/s, i.e., half of normal speed)
Able to stand without assistance
Disqualifiers
Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task
Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games
Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games
Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment
Trial design
Treatments tested in this trial
- myoelectric interface for neurorehabilitation (MINT) conditioning
- One muscle myoelectric feedback
Treatment groups
72 Participants
are divided into 2 treatment groupsSponsors and collaborators
Northwestern University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
University of Texas Southwestern Medical Center
Collaborator
Source ClinicalTrials.gov